Drug Profile
Research programme: antiviral therapeutics - US Phytotherapy
Alternative Names: PROACT D; PROACT-ZLatest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator US Phytotherapy
- Class Antimalarials; Antivirals; Artemisinins; Berberine alkaloids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chikungunya virus infections; Dengue; Malaria; Yellow fever; Zika virus infection
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Chikungunya virus infections in USA (unspecified route), prior to September 2023
- 04 Sep 2023 Discontinued - Preclinical for Dengue in USA (unspecified route), prior to September 2023
- 04 Sep 2023 Discontinued - Preclinical for Malaria in USA (unspecified route), prior to September 2023